URO1 is an early stage medical products developer for urology procedures.
URO-1 has raised $8.0M in total funding. The most recent round was Series A. The last funding was announced in March 2024.
URO-1's investors include Acorn Campus Taiwan.
URO-1 is headquartered in Winston Salem, United States.
URO1 is an early stage medical products developer for urology procedures.
URO-1 is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"URO-1 — Funding & Investors." VCBacked, March 27, 2024, https://www.vcbacked.co/company/uro-1. Accessed August 1, 2026.
VCBacked. (2024). URO-1 — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/uro-1
{{cite web |title=URO-1 — Funding & Investors |url=https://www.vcbacked.co/company/uro-1 |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated